These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda? Kironde S; Lukwago J; Ssenyonga R Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802 [No Abstract] [Full Text] [Related]
44. Nevirapine reduced mother-to-child transmission better than AZT--at 70 times less the cost. AIDS Treat News; 2003 Sep; (394):7. PubMed ID: 14669729 [TBL] [Abstract][Full Text] [Related]
45. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983 [TBL] [Abstract][Full Text] [Related]
46. A saga in international HIV policy modeling: preventing mother-to-child HIV transmission. Kahn JG; Marseille E J Policy Anal Manage; 2002; 21(3):499-505. PubMed ID: 12725210 [No Abstract] [Full Text] [Related]
47. Should research ethics change at the border? Lurie P; Wolfe SM Med J Aust; 1999 Aug; 171(3):167-8. PubMed ID: 10474616 [No Abstract] [Full Text] [Related]
49. Recent advances in prevention of mother to child (PMTCT) of HIV. Musoke P Afr Health Sci; 2004 Dec; 4(3):144-5. PubMed ID: 15687065 [No Abstract] [Full Text] [Related]
50. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces. Plipat T; Naiwatanakul T; Rattanasuporn N; Sangwanloy O; Amornwichet P; Teeraratkul A; Ungchusak K; Mock P; Levine W; McConnell MS; Simonds R; Culnane M AIDS; 2007 Jan; 21(2):145-51. PubMed ID: 17197804 [TBL] [Abstract][Full Text] [Related]
51. HIV drug remains unproven without placebo trial. Turner VF Nature; 2005 Mar; 434(7030):137. PubMed ID: 15758970 [No Abstract] [Full Text] [Related]
52. Information from your family doctor. HIV and pregnancy. Am Fam Physician; 2002 May; 65(10):2125-6. PubMed ID: 12046783 [No Abstract] [Full Text] [Related]
53. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks. Mellors JW; Chow JY Clin Infect Dis; 2009 Feb; 48(4):473-5. PubMed ID: 19133800 [No Abstract] [Full Text] [Related]
54. Hope emerges for controlling perinatal HIV transmission. Klosinski L Posit Living; 1999 Aug; 8(7):19, 23. PubMed ID: 12492079 [No Abstract] [Full Text] [Related]
55. Perinatal transmission--successful interventions. Where do we go from here? Wilfert CM; Fleming T Int J STD AIDS; 1998; 9 Suppl 1():22-7. PubMed ID: 9874113 [No Abstract] [Full Text] [Related]
56. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV. Goulder PJ; Blanckenberg N; Dong K N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15529448 [No Abstract] [Full Text] [Related]
57. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650 [TBL] [Abstract][Full Text] [Related]
59. Routine provision of nevirapine to women of unknown serostatus: at best a temporary solution to prevent MTCT. Newell ML Bull World Health Organ; 2005 Mar; 83(3):228-9. PubMed ID: 15798848 [No Abstract] [Full Text] [Related]